Litcius/Paper detail

T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2

Jennifer L. Welch, Jinhua Xiang, Qing Chang, Jon C. D. Houtman, Jack T. Stapleton

2021The Journal of Infectious Diseases22 citationsDOIOpen Access PDF

Abstract

The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not completely understood. SARS-CoV-2 infection frequently causes significant immune function consequences including reduced T cell numbers and enhanced T cell exhaustion that contribute to disease severity. The extent to which T cell effects are directly mediated through infection or indirectly result from infection of respiratory-associated cells is unclear. We show that primary human T cells express sufficient levels of angiotensin converting enzyme 2 (ACE-2), the SARS-CoV-2 receptor, to mediate viral binding and entry into T cells. We further show that T cells exposed to SARS-CoV-2 particles demonstrate reduced proliferation and apoptosis compared to uninfected controls, indicating that direct interaction of SARS-CoV-2 with T cells may alter T cell growth, activation, and survival. Regulation of T cell activation and/or turnover by SARS-CoV-2 may contribute to impaired T cell function observed in patients with severe disease.

Topics & Concepts

T cellPathogenesisImmunologyImmune systemCoronavirusBiologyCell growthCellReceptorRespiratory systemMedicineDiseaseInternal medicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)GeneticsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19